{
  "ticker": "CR3",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02960444",
  "id": "02960444",
  "pages": 30,
  "price_sensitive": false,
  "date": "20250620",
  "time": "1223",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250620/pdf/06ky8q3l6cxrz7.pdf",
  "summary": "### **Material Information Summary (General Meeting Notice)**  \n\n#### **Key Resolutions for Capital Markets Impact:**  \n1. **Ratification of Prior Issue (Resolution 1)**  \n   - Ratifies Tranche 1 Convertible Notes (286,235 notes, $286,235 face value) issued under ASX Listing Rule 7.1.  \n   - Issued on 10 June 2025; conversion price: lower of **$0.02** or 15% discount to 15-day VWAP (floor: **$0.005**).  \n\n2. **Approval of Tranche 2 Convertible Notes (Resolution 2)**  \n   - Seeks approval for **$1,713,765** (1,713,765 notes) under ASX Listing Rule 7.1.  \n   - Terms identical to Tranche 1.  \n\n3. **Free Attaching Options (Resolution 3)**  \n   - Issuance of **20,000,000 options** (10:1 ratio per $1 note subscribed).  \n   - Exercise price: **$0.035**; expiry **31 March 2027**.  \n\n4. **Broker Options (Resolution 4)**  \n   - **46,299,000 options** to GBA Capital (6% fee on $1.403M tranche).  \n   - Same terms as free options ($0.035 exercise, 31 March 2027 expiry).  \n\n5. **Director Performance Rights (Resolutions 5\u20138)**  \n   - **29.1M performance rights** to four directors.  \n   - Vesting tied to resource milestones (e.g., 8Mlb/16Mlb JORC uranium) or market cap targets ($15M/$25M).  \n\n#### **Timetable:**  \n- **Record Date:** 21 July 2025 (10:30am WST).  \n- **Meeting Date:** 23 July 2025 (10:30am WST, Perth).  \n\n#### **Capital Structure Implications:**  \n- **Maximum Dilution Scenarios** (assuming full conversion):  \n  - **Tranche 1 Notes:** Up to **57.2M shares** (12.7% dilution at floor price).  \n  - **Tranche 2 Notes:** Up to **342.8M shares** (46.5% dilution at floor price).  \n  - **Options/Performance Rights:** Additional **96.4M shares** if fully exercised/converted.  \n\n#### **Voting Exclusions:**  \n- Related parties (e.g., noteholders, directors) excluded from voting on relevant resolutions.  \n\n**Action:** Monitor dilution risks and director incentive alignment. No immediate trading impact pending meeting outcomes.",
  "usage": {
    "prompt_tokens": 20162,
    "completion_tokens": 571,
    "total_tokens": 20733,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-20T03:07:28.160914"
}